FDA Clearance Tracker · P950032-S022
APLIGRAF(GRAFTSKIN)
Last checked: Nov 20, 2026Latest source record: Apr 26, 2001 (this decision)Source: openFDAMethods & limitations
Decided
Apr 26, 2001
Approved
Time to decision
99 days
Received Jan 17, 2001. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P950032-S022
- Device name
- APLIGRAF(GRAFTSKIN)
- Applicant
- Organogenesis, Inc.
- Applicant location
- Canton, MA
- Received
- Jan 17, 2001
- Decided
- Apr 26, 2001
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P950032
Device type
- Device type
- Dressing, wound and burn, interactive (MGR)
- Device class
- Class III
- Specialty
- General & Plastic SurgeryWound Care
FDA's approval statement
As written in FDA's record.
APPROVAL FOR REPLACEMENT OF THE SOYBEAN TRYPSIN INHIBITOR REAGENT IN APLIGRAF MANUFACTURE WITH THE NEWLY DEFINED TRYPSIN QUENCHING MEDIUM.
Source documents
Other decisions for Organogenesis, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K212579 · Decided May 2, 2023 · 624 days after receipt
Device type: Wound Dressing With Animal-Derived Material(S) (KGN) · General & Plastic Surgery
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.